Abstract
BackgroundPaediatric patients are one of the most vulnerable patient populations. There are many unlicensed medicines and the so-called ‘off-label’ uses for which they are prescribed may increase the risk of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: European Journal of Hospital Pharmacy: Science and Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.